Regarding the GABAergic pathway, a loss of glutamatergic pyramidal cells and calbindin-D28k-immunoreactive GABAergic neurons in the frontal and temporal cortices of patients with FTLD[39] and FTLD with motor neuron disease[40] was reported. The gene discussed is CALB1; the disease is motor neuron disorder.